image
Passage Bio, Inc. PASG
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.3403
8.39 %
$ 21.1 M
Market Cap
-0.33
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
44.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Passage Bio, Inc.
image
PASG has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart PASG

image
$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart PASG

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart PASG

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029